Emerging Biomaterials-Based Strategies for Inhibiting Vasculature Function in Cancer Therapy

Minting Liu1, Caisheng Wu1, Lingjie Ke1

  • 1Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.

Small Methods
|December 20, 2021
PubMed

Insights

Targeting tumor blood vessels with nanotherapeutics offers a novel cancer treatment strategy. This review details biomaterial-based approaches to block nutrient and oxygen supply, starving tumors for effective cancer therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Tumor growth relies on continuous oxygen and nutrient supply via blood vasculature.
  • Nanotherapeutics targeting tumor vasculature show promise for cancer treatment via starvation therapy.
  • Existing strategies for vascular disruption are not comprehensively reviewed.

Purpose of the Study:

  • To provide an exhaustive summary of biomaterial-based strategies for disrupting tumor vascular function.
  • To highlight nanotherapeutic approaches for cancer treatment.
  • To inform the design of anti-cancer nanomedicine targeting the tumor vascular system.

Main Methods:

  • Review of existing literature on biomaterial-based strategies.
  • Categorization of methods including hydrogel/nanogel-mediated arterial embolism.
  • Analysis of thrombosis activator-loaded nanomaterials for vascular occlusion.
  • Examination of anti-vascular drugs targeting tumor vasculature.

Main Results:

  • Identification of diverse biomaterial-based strategies to disrupt tumor blood vessels.
  • Demonstration of nanotherapeutic potential in starving tumors.
  • Compilation of methods for local arterial embolism and vascular occlusion.
  • Overview of anti-vascular drugs impacting tumor vascular function.

Conclusions:

  • Biomaterial-based strategies effectively disrupt tumor vascular function.
  • Nanotherapeutics offer a promising avenue for cancer starvation therapy.
  • Targeting the tumor vascular system is a key strategy for developing novel anti-cancer nanomedicine.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K